| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Daniel E Casey, David G Daniel, Carol Tamminga, John M Kane, Tram Tran-Johnson, Patricia Wozniak, Walid Abi-Saab, Jeff Baker, Laura Redden, Nicholas Greco, Mario Saltarell. Divalproex ER combined with olanzapine or risperidone for treatment of acute exacerbations of schizophrenia. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 34. issue 5. 2009-05-07. PMID:19052541. |
the objective of this study was to evaluate the efficacy and safety of divalproex sodium extended release (divalproex er) vs placebo in combination with olanzapine or risperidone for the treatment of acute exacerbations of schizophrenia. |
2009-05-07 |
2023-08-12 |
Not clear |
| Claire Chevreuil, Jean-Michel Reymann, Tanya Frémaux, Elisabeth Polard, Tanguy Séveno, Danièle Bentué-Ferre. [Risperidone use in child and adolescent psychiatric patients]. Therapie. vol 63. issue 5. 2009-04-27. PMID:19154706. |
risperidone has proved helpful in treating children and adolescents with autism spectrum, conduct and bipolar disorders, tourette's syndrome, and schizophrenia. |
2009-04-27 |
2023-08-12 |
Not clear |
| Dattatreya Mendhekar, Deep Lohi. Risperidone therapy in two successive pregnancies. The Journal of neuropsychiatry and clinical neurosciences. vol 20. issue 4. 2009-04-23. PMID:19196935. |
the authors report a case of a woman with schizophrenia wherein risperidone was used successfully in two consecutive pregnancies. |
2009-04-23 |
2023-08-12 |
Not clear |
| Deanna L Kelly, Heidi J Wehring, Jared Linthicum, Stephanie Feldman, Robert P McMahon, Raymond C Love, Tara Wagner, Joo Cheol Shim, David R Fowle. Cardiac-related findings at autopsy in people with severe mental illness treated with clozapine or risperidone. Schizophrenia research. vol 107. issue 2-3. 2009-04-20. PMID:19028422. |
this study examined all available autopsy data on cardiac disease and risk factors in people with schizophrenia in a sample of deceased persons with severe mental illness who had received clozapine (n=62) or risperidone (n=42). |
2009-04-20 |
2023-08-12 |
Not clear |
| Matthew J Byerly, Ronald N Marcus, Quynh-Van Tran, James M Eudicone, Richard Whitehead, Ross A Bake. Effects of aripiprazole on prolactin levels in subjects with schizophrenia during cross-titration with risperidone or olanzapine: analysis of a randomized, open-label study. Schizophrenia research. vol 107. issue 2-3. 2009-04-20. PMID:19038534. |
effects of aripiprazole on prolactin levels in subjects with schizophrenia during cross-titration with risperidone or olanzapine: analysis of a randomized, open-label study. |
2009-04-20 |
2023-08-12 |
human |
| Matthew J Byerly, Ronald N Marcus, Quynh-Van Tran, James M Eudicone, Richard Whitehead, Ross A Bake. Effects of aripiprazole on prolactin levels in subjects with schizophrenia during cross-titration with risperidone or olanzapine: analysis of a randomized, open-label study. Schizophrenia research. vol 107. issue 2-3. 2009-04-20. PMID:19038534. |
this post-hoc sub-analysis of an 8-week, open-label study in outpatients with schizophrenia (cn138-215) examined short-term effects on prolactin levels during a switch from risperidone or olanzapine to aripiprazole 30 mg/day. |
2009-04-20 |
2023-08-12 |
human |
| Terry E Goldberg, Katherine E Burdick, Joanne McCormack, Barbara Napolitano, Raman C Patel, Serge M Sevy, Robert Goldman, Todd Lencz, Anil K Malhotra, John M Kane, Delbert G Robinso. Lack of an inverse relationship between duration of untreated psychosis and cognitive function in first episode schizophrenia. Schizophrenia research. vol 107. issue 2-3. 2009-04-20. PMID:19042105. |
one hundred two patients with first episode schizophrenia or schizoaffective disorder were assessed on cognitive measures of speed of processing, episodic memory, executive function, and visual spatial processing at baseline (when patients were drug naive and after 16 weeks of olanzapine or risperidone treatment), so that a change score could be derived. |
2009-04-20 |
2023-08-12 |
Not clear |
| Maarten Treur, Bart Heeg, Hans-Jürgen Möller, Annette Schmeding, Ben van Hou. A pharmaco-economic analysis of patients with schizophrenia switching to generic risperidone involving a possible compliance loss. BMC health services research. vol 9. 2009-04-20. PMID:19226465. |
a pharmaco-economic analysis of patients with schizophrenia switching to generic risperidone involving a possible compliance loss. |
2009-04-20 |
2023-08-12 |
Not clear |
| Shahin Akhondzadeh, Maryam Gerami, Maryam Noroozian, Narges Karamghadiri, Aboulfazl Ghoreishi, Seyed-Hesameddin Abbasi, Sams-Ali Rezazade. A 12-week, double-blind, placebo-controlled trial of donepezil adjunctive treatment to risperidone in chronic and stable schizophrenia. Progress in neuro-psychopharmacology & biological psychiatry. vol 32. issue 8. 2009-04-15. PMID:18727948. |
a 12-week, double-blind, placebo-controlled trial of donepezil adjunctive treatment to risperidone in chronic and stable schizophrenia. |
2009-04-15 |
2023-08-12 |
human |
| Shahin Akhondzadeh, Mojgan Malek-Hosseini, Aboulfazl Ghoreishi, Maedeh Raznahan, Shams-Ali Rezazade. Effect of ritanserin, a 5HT2A/2C antagonist, on negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study. Progress in neuro-psychopharmacology & biological psychiatry. vol 32. issue 8. 2009-04-15. PMID:18801405. |
this study was designed to investigate the effect of ritanserin added to risperidone as augmentation therapy in patients with chronic schizophrenia and prominent negative symptoms in a double blind and randomized clinical trial. |
2009-04-15 |
2023-08-12 |
human |
| L N Gorobet. Contribution of leptin to the formation of neuroleptic obesity in patients with schizophrenia during antipsychotic therapy. Bulletin of experimental biology and medicine. vol 146. issue 3. 2009-03-30. PMID:19240857. |
we studied the dynamics of serum leptin level and some anthropometric values in patients with schizophrenia treated with risperidone, olanzapine, and clozapine showed gender-dependent specific correlations between the studied parameters. |
2009-03-30 |
2023-08-12 |
Not clear |
| Beata Konarzewska, Sławomir Wołczyński, Agata Szulc, Beata Galińska, Regina Popławska, Napoleon Waszkiewic. Effect of risperidone and olanzapine on reproductive hormones, psychopathology and sexual functioning in male patients with schizophrenia. Psychoneuroendocrinology. vol 34. issue 1. 2009-03-24. PMID:18838228. |
effect of risperidone and olanzapine on reproductive hormones, psychopathology and sexual functioning in male patients with schizophrenia. |
2009-03-24 |
2023-08-12 |
Not clear |
| Josep Maria Haro, Diego Novick, David Suarez, Mercedes Roc. Antipsychotic treatment discontinuation in previously untreated patients with schizophrenia: 36-month results from the SOHO study. Journal of psychiatric research. vol 43. issue 3. 2009-03-19. PMID:18644606. |
data from the 3-year, prospective, observational soho study were used to compare the effectiveness (in terms of treatment discontinuation) and the tolerability of olanzapine, risperidone, other atypicals and typical antipsychotics in 1009 previously untreated outpatients with schizophrenia who started monotherapy at baseline. |
2009-03-19 |
2023-08-12 |
Not clear |
| Natalie C Edwards, Jacqueline Pesa, Dennis M Meletiche, Luella Engelhart, Ann K Thompson, Jay Sherr, Riad Diran. One-year clinical and economic consequences of oral atypical antipsychotics in the treatment of schizophrenia. Current medical research and opinion. vol 24. issue 12. 2009-03-18. PMID:18954497. |
to assess the clinical and economic consequences of oral atypical antipsychotic treatment (aripiprazole, olanzapine, paliperidone er, quetiapine, risperidone, and ziprasidone) in schizophrenia over one-year from a us healthcare system perspective. |
2009-03-18 |
2023-08-12 |
Not clear |
| Martin Dossenbach, Jan Pecenak, Agata Szulc, Victoria Irimia, Martin Anders, Dusanka Logozar-Perkovic, Dalia Peciukaitiene, Moshe Kotler, Anatoly B Smulevich, Teena M West, Amanda J Lowry, Tamas Treue. Long-term antipsychotic monotherapy for schizophrenia: disease burden and comparative outcomes for patients treated with olanzapine, quetiapine, risperidone, or haloperidol monotherapy in a pan-continental observational study. The Journal of clinical psychiatry. vol 69. issue 12. 2009-03-06. PMID:19012820. |
long-term antipsychotic monotherapy for schizophrenia: disease burden and comparative outcomes for patients treated with olanzapine, quetiapine, risperidone, or haloperidol monotherapy in a pan-continental observational study. |
2009-03-06 |
2023-08-12 |
Not clear |
| Ronette L Kolotkin, Patricia K Corey-Lisle, Ross D Crosby, Hong J Kan, Robert D McQuad. Changes in weight and weight-related quality of life in a multicentre, randomized trial of aripiprazole versus standard of care. European psychiatry : the journal of the Association of European Psychiatrists. vol 23. issue 8. 2009-03-05. PMID:18374544. |
we examined changes in weight and weight-related quality of life among community patients with schizophrenia treated with aripiprazole (ari) versus standard of care (soc), consisting of other marketed atypical antipsychotics (olanzapine, quetiapine, and risperidone). |
2009-03-05 |
2023-08-12 |
Not clear |
| Norio Yasui-Furukori, Yasushi Sato, Hanako Furukori, Manabu Saito, Taku Nakagami, Sunao Kanek. Glucose metabolism in Japanese schizophrenia patients treated with risperidone or olanzapine. The Journal of clinical psychiatry. vol 70. issue 1. 2009-03-05. PMID:19026267. |
glucose metabolism in japanese schizophrenia patients treated with risperidone or olanzapine. |
2009-03-05 |
2023-08-12 |
Not clear |
| Linda Hanssens, Gilbert L'Italien, Jean-Yves Loze, Ronald N Marcus, Miranda Pans, Wendy Kerselaer. The effect of antipsychotic medication on sexual function and serum prolactin levels in community-treated schizophrenic patients: results from the Schizophrenia Trial of Aripiprazole (STAR) study (NCT00237913). BMC psychiatry. vol 8. 2009-03-05. PMID:19102734. |
the aim of this paper is to evaluate the effect of antipsychotics for the treatment of schizophrenia in a community based study on sexual function and prolactin levels comparing the use of aripiprazole and standard of care (soc), which was a limited choice of three widely used and available antipsychotics (olanzapine, quetiapine or risperidone) (the schizophrenia trial of aripiprazole [star] study [nct00237913]). |
2009-03-05 |
2023-08-12 |
Not clear |
| Nada Bozina, Nikolina Jovanović, Mila Lovrić, Vesna Medve. Clinical significance of a CYP2D6 poor metabolizer--a patient with schizophrenia on risperidone treatment. Therapeutic drug monitoring. vol 30. issue 6. 2009-03-03. PMID:18806696. |
clinical significance of a cyp2d6 poor metabolizer--a patient with schizophrenia on risperidone treatment. |
2009-03-03 |
2023-08-12 |
Not clear |
| Nada Bozina, Nikolina Jovanović, Mila Lovrić, Vesna Medve. Clinical significance of a CYP2D6 poor metabolizer--a patient with schizophrenia on risperidone treatment. Therapeutic drug monitoring. vol 30. issue 6. 2009-03-03. PMID:18806696. |
a case of a 46-year-old woman with schizophrenia who was treated with risperidone and followed up for 1 year is reported. |
2009-03-03 |
2023-08-12 |
Not clear |